Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
19 December, 2018 13:16 IST
Fitch affirms Tata Motors at BB+; Outlook Stable
Source: IRIS | 27 Apr, 2018, 12.18PM
Comments  |  Post Comment

Fitch Ratings has affirmed India-based Tata Motors (TML) Long-Term Issuer Default Rating at 'BB+'. The Outlook is Stable.

TML's rating, which includes a one-notch uplift from its standalone rating of 'BB' on its linkage with Tata Sons (TSOL), reflects its leading position in India's commercial-vehicle market and the passenger-vehicle business, which is recovering after the success of new product launches in recent years.

TML's rating also reflects its 100%-owned subsidiary Jaguar Land Rover Automotive plc's (JLR, BB+/Stable) strong positioning in the premium segment and a financial profile that will remain solid even after considering substantial investments for capacity expansion and new technologies over the next few years. JLR's EBITDA accounted for more than 85% of TML's consolidated EBITDA in the fiscal year ended 31 March 2017 (FY17).

The Stable Outlook reflects Fitch's expectations of gradually improving profitability and strong financial flexibility, which will help to meet significant investment requirements, especially in the JLR business, without any liquidity concerns and support TML's leverage at a level commensurate with the current rating.

Shares of the company gained Rs 2.55, or 0.77%, to trade at Rs 332.85. The total volume of shares traded was 233,443 at the BSE (12.07 p.m., Friday).





Tata Motors Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
Commercial Engineers & Body Builders Company wins order worth Rs 1.52 bn - 19-Dec-2018 10:51
Glenmark Pharmaceuticals forays into branded dermatology segment in U.S. - 19-Dec-2018 10:33
M&M to hike stake in associate company Sampo Rosenlew - 18-Dec-2018 10:37
Glenmark Pharma gets nod for Fluocinolone Acetonide oil - 18-Dec-2018 10:08
BGR Energy Systems bags order worth Rs 494 mn from Tamilnadu Transmission Corp - 18-Dec-2018 10:04
Lupin receives approval from USFDA for Clobazam tablets - 18-Dec-2018 10:01
Ahluwalia Contracts (India) secures new order worth RS 4.25 bn - 17-Dec-2018 15:31
Lupin receives tentative USFDA approval for Tadalafil tablets - 17-Dec-2018 14:49
Gayatri Projects bags new order worth Rs 4.93 bn - 17-Dec-2018 09:43
Zydus Cadila receives USFDA approvals for two drugs - 17-Dec-2018 09:39
Biocon's API manufacturing facility completes USFDA inspection - 17-Dec-2018 09:36
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer